Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Last Close
217.61
Oct 30 • 3:59 PM ET Dollar change-0.25 Percentage change(-0.11%)
Aftermarket Close
218.00
Aftermarket • 7:53 PM ET Dollar change+0.39 Percentage change(0.18%)
Category
US Equities - Industry Sector
Sponsor
Blackrock (iShares)
Fund Family
Index
ICE Biotechnology Index
Index Weighting
Active/Passive
Expense
0.44%
Inverse/Leveraged
IPO
Feb 09, 2001
Asset Type
Equities (Stocks)
ETF Type
Bond Type
Average Maturity
Commodity Type
Quant Type
ESG Type
Dividend Type
Structure Type
Growth/Value
Market Cap
Option/Short
Yes / Yes
Tags
Tags
Tags
Tags
-
Tags
-
Tags
-
Tags
-
Sector/Theme
Region
SMA20
4.76%
SMA50
4.41%
SMA200
17.79%
Return% 1Y
38.46%
Return% 3Y
23.20%
Return% 5Y
6.78%
Return% 10Y
Return% SI
Flows% 1M
-0.30%
Flows% 3M
7.05%
Flows% YTD
7.47%
Flows% 1Y
Flows% 3Y
Flows% 5Y
Trades
Total Holdings
249
AUM
11.52B
NAV/sh
52W High
220.31 -1.23%
52W Low
154.62 40.74%
Volatility
2.56% 2.41%
ATR (14)
4.98
RSI (14)
62.80
Beta
0.73
Rel Volume
2.14
Avg Volume
1.62M
Volume
3,456,517
Perf Week
4.75%
Perf Month
5.66%
Perf Quarter
17.05%
Perf Half Y
30.10%
Perf YTD
28.94%
Perf Year
38.33%
Perf 3Y
92.52%
Perf 5Y
36.35%
Perf 10Y
150.74%
Prev Close
217.86
Price
217.61
Change %
-0.11%
iShares Biotechnology ETF seeks to track the investment results of the ICE Biotechnology Index composed of U.S.-listed equities in the biotechnology sector. The fund generally will invest at least 80% of its assets in the component securities of its index and in investments that have economic characteristics that are substantially identical to the component securities of its index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.